Literature DB >> 10983976

E2F4 is essential for normal erythrocyte maturation and neonatal viability.

P O Humbert1, C Rogers, S Ganiatsas, R L Landsberg, J M Trimarchi, S Dandapani, C Brugnara, S Erdman, M Schrenzel, R T Bronson, J A Lees.   

Abstract

The retinoblastoma protein (pRB) plays a key role in the control of normal development and proliferation through the regulation of the E2F transcription factors. We generated a mutant mouse model to assess the in vivo role of the predominant E2F family member, E2F4. Remarkably, loss of E2F4 had no detectable effect on either cell cycle arrest or proliferation. However, E2F4 was essential for normal development. E2f4-/- mice died of an increased susceptibility to opportunistic infections that appeared to result from craniofacial defects. They also displayed a variety of erythroid abnormalities that arose from a cell autonomous defect in late stage maturation. This suggests that E2F4 makes a major contribution to the control of erythrocyte development by the pRB tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10983976     DOI: 10.1016/s1097-2765(00)00029-0

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  88 in total

1.  E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.

Authors:  H Müller; A P Bracken; R Vernell; M C Moroni; F Christians; E Grassilli; E Prosperini; E Vigo; J D Oliner; K Helin
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

2.  E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis.

Authors:  J W Zhu; S J Field; L Gore; M Thompson; H Yang; Y Fujiwara; R D Cardiff; M Greenberg; S H Orkin; J DeGregori
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  The role of E2F4 in adipogenesis is independent of its cell cycle regulatory activity.

Authors:  Rebecca L Landsberg; Julia E Sero; Paul S Danielian; Tina L Yuan; Eunice Y Lee; Jacqueline A Lees
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

4.  Constitutive E2F1 overexpression delays endochondral bone formation by inhibiting chondrocyte differentiation.

Authors:  Blanca Scheijen; Marieke Bronk; Tiffany van der Meer; René Bernards
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

5.  Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice.

Authors:  Feng X Li; Jing W Zhu; Christopher J Hogan; James DeGregori
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

6.  The transcriptional repressor gene Mad3 is a novel target for regulation by E2F1.

Authors:  Elizabeth J Fox; Stephanie C Wright
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

7.  Specificity in the activation and control of transcription factor E2F-dependent apoptosis.

Authors:  Timothy C Hallstrom; Joseph R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-03       Impact factor: 11.205

8.  Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells.

Authors:  Mira T Kassouf; Jim R Hughes; Stephen Taylor; Simon J McGowan; Shamit Soneji; Angela L Green; Paresh Vyas; Catherine Porcher
Journal:  Genome Res       Date:  2010-06-21       Impact factor: 9.043

9.  Two Distinct E2F Transcriptional Modules Drive Cell Cycles and Differentiation.

Authors:  Maria C Cuitiño; Thierry Pécot; Daokun Sun; Raleigh Kladney; Takayuki Okano-Uchida; Neelam Shinde; Resham Saeed; Antonio J Perez-Castro; Amy Webb; Tom Liu; Soo In Bae; Linda Clijsters; Nicholas Selner; Vincenzo Coppola; Cynthia Timmers; Michael C Ostrowski; Michele Pagano; Gustavo Leone
Journal:  Cell Rep       Date:  2019-05-23       Impact factor: 9.423

10.  Osteopenia in Sparc (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression.

Authors:  Fiona C Mansergh; Timothy Wells; Carole Elford; Samuel L Evans; Mark J Perry; Martin J Evans; Bronwen A J Evans
Journal:  Physiol Genomics       Date:  2007-09-18       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.